Mahua Sarkar to Humans
This is a "connection" page, showing publications Mahua Sarkar has written about Humans.
Connection Strength
0.108
-
Sarkar M, Du T, Chen Y, Lawrence YVM, Ma J, Khan SA, Oyelere AK, Liang D, Gao S, Xie H. Preclinical Development of GT-14, a Novel Inhibitor of Gai2 Protein: Comprehensive Evaluation of Physicochemical, Metabolic Characteristics and Tissue Distribution. AAPS J. 2025 12 01; 28(1):23.
Score: 0.043
-
Sarkar M, Wang Y, Ekpenyong O, Liang D, Xie H. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 03; 15(2):e1846.
Score: 0.034
-
Sarkar M, Grossman RG, Toups EG, Chow DS. UPLC-MS/MS assay of riluzole in human plasma and cerebrospinal fluid (CSF): Application in samples from spinal cord injured patients. J Pharm Biomed Anal. 2017 Nov 30; 146:334-340.
Score: 0.024
-
Nguyen A, Chow DS, Wu L, Teng YA, Sarkar M, Toups EG, Harrop JS, Schmitt KM, Johnson MM, Guest JD, Aarabi B, Shaffrey CI, Boakye M, Frankowski RF, Fehlings MG, Grossman RG. Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent. J Clin Pharmacol. 2021 09; 61(9):1232-1242.
Score: 0.008